Search by Drug Name or NDC

    NDC 23594-0250-01 Cefaclor 250 mg/5mL Details

    Cefaclor 250 mg/5mL

    Cefaclor is a ORAL FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aytu Therapeutics, LLC. The primary component is CEFACLOR.

    Product Information

    NDC 23594-0250
    Product ID 23594-250_bf7dced3-822e-df9b-e053-2995a90ae2e7
    Associated GPIs 02200040001910
    GCN Sequence Number 009108
    GCN Sequence Number Description cefaclor SUSP RECON 250 MG/5ML ORAL
    HIC3 W1X
    HIC3 Description CEPHALOSPORIN ANTIBIOTICS - 2ND GENERATION
    GCN 40031
    HICL Sequence Number 003983
    HICL Sequence Number Description CEFACLOR
    Brand/Generic Generic
    Proprietary Name Cefaclor
    Proprietary Name Suffix n/a
    Non-Proprietary Name cefaclor
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form FOR SUSPENSION
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/5mL
    Substance Name CEFACLOR
    Labeler Name Aytu Therapeutics, LLC
    Pharmaceutical Class Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA065412
    Listing Certified Through 2022-12-31

    Package

    NDC 23594-0250-01 (23594025001)

    NDC Package Code 23594-250-01
    Billing NDC 23594025001
    Package 150 mL in 1 BOTTLE, PLASTIC (23594-250-01)
    Marketing Start Date 2015-10-26
    NDC Exclude Flag N
    Pricing Information N/A